Abstract
Human hemoglobin is an essential protein, whose main function as an oxygen carrier is indispensable for life. Hemoglobin is a cofactor-containing protein with heme as prosthetic group. Same as in humans, heme is synthesized in many organisms in a complex pathway involving two cellular compartments (mitochondria and cytosol), which is tightly regulated. Red blood cells (erythrocytes) are specialized and adapted for production and transport of the hemoglobin molecules. In addition to oxygen binding, hemoglobin can participate in a variety of chemical reactions by its iron and heme and may become toxic when released from erythrocytes. Hemoglobin is a major target for the development of blood substitutes/oxygen carriers, and therefore its microbial production is attractive, as it may provide a cheap and reliable source of human hemoglobin. Significant efforts have been dedicated to this task for the last three decades. Moreover since the first generation of cell-free blood substitutes based on unmodified hemoglobin failed human trials, mutant forms became of great interest.
In this chapter we summarize the existing knowledge about human hemoglobin, challenges of its microbial production, and its improvement, with a particular focus upon yeast as production host.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Prabhulkar S, Tian H, Wang X et al (2012) Engineered proteins: redox properties and their applications. Antioxid Redox Signal 17(12):1796–1822
Lončar N, Fraaije MW (2015) Catalases as biocatalysts in technical applications: current state and perspectives. Appl Microbiol Biotechnol 99(8):3351–3357
Bankar SB, Bule MV, Singhal RS et al (2009) Glucose oxidase – an overview. Biotechnol Adv 27(4):489–501
Kim DH, Kim MS (2011) Hydrogenases for biological hydrogen production. Bioresour Technol 102(18):8423–8431
Antonini E, Brunori M (1971) Hemoglobin and myoglobin in their reactions with ligands. In: Neuberger A, Tatum EL (eds) Frontiers of biology, vol 21. North-Holland Publishing Company, Amsterdam, p 436
Messerschmidt A (2001) Handbook of metalloproteins. Wiley, Chichester
Kumar S, Stecher G, Tamura K (2016) MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 33:1870–1874
Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425
Zuckerkandl E, Pauling L (1965) Evolutionary divergence and convergence in proteins. In: Bryson V, Vogel HJ (eds) Evolving genes and proteins. Academic Press, New York, pp 97–166
Moraes CT, Diaz F, Barrientos A (2004) Defects in the biosynthesis of mitochondrial heme c and heme a in yeast and mammals. Biochim Biophys Acta 1659(2–3):153–159
Berg JM, Tymoczko JL, Stryer L (eds) (2002) Biochemistry. W. H. Freeman, New York
Benesch R, Benesch RE (1967) The effect of organic phosphates from the human erythrocyte on the allosteric properties of hemoglobin. Biochem Biophys Res Commun 26(2):162–167
Bohr C, Hasselbalch K, Krogh A (1904) Concerning a biologically important relationship – the influence of the carbon dioxide content of blood on its oxygen binding. Skand Arch Physiol 16:402–412 [In German]
Farber HW, Loscalzo J (2004) Pulmonary arterial hypertension. N Engl J Med 351(16):1655–1665
Schaer DJ, Buehler PW (2013) Cell-free hemoglobin and its scavenger proteins: new disease models leading the way to targeted therapies. Cold Spring Harb Perspect Med 3(6):a013433
Doherty DH, Doyle MP, Curry SR (1998) Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 16(7):672–676
Olson JS, Foley EW, Rogge C et al (2004) No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 36(6):685–697
Alayash AI, Patel RP, Cashon RE (2001) Redox reactions of hemoglobin and myoglobin: biological and toxicological implications. Antioxid Redox Signal 3(2):313–327
Piantadosi CA (2002) Biological chemistry of carbon monoxide. Antioxid Redox Signal 4(2):259–270
Tsantes AE, Bonovas S, Travlou A et al (2006) Redox imbalance, macrocytosis, and RBC homeostasis. Antioxid Redox Signal 8(7–8):1205–1216
Johnson RM, Ho YS, Yu DY et al (2010) The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism. Free Radic Biol Med 48(4):519–525
Smith A, McCulloh RJ (2015) Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders. Front Physiol 6:187. https://doi.org/10.3389/fphys.2015.00187
Rochette J, Craig JE, Thein SL (1994) Fetal hemoglobin levels in adults. Blood Rev 8(4):213–224
Manca L, Masala B (2008) Disorders of the synthesis of human fetal hemoglobin. IUBMB Life 60(2):94–111
Steinberg MH, Rodgers GP (2015) HbA2: biology, clinical relevance and a possible target for ameliorating sickle cell disease. Br J Haematol 170(6):781–787
Peschle C, Mavilio F, Carè A et al (1985) Haemoglobin switching in human embryos: asynchrony of zeta-alpha and epsilon-gamma-globin switches in primitive and definite erythropoietic lineage. Nature 313(5999):235–238
Al-Mufti R, Hambley H, Farzaneh F et al (2000) Fetal and embryonic hemoglobins in erythroblasts of chromosomally normal and abnormal fetuses at 10–40 weeks of gestation. Haematologica 85(7):690–693
He Z, Russell JE (2001) Expression, purification, and characterization of human hemoglobins Gower-1 (zeta(2)epsilon(2)), Gower-2 (alpha(2)epsilon(2)), and Portland-2 (zeta(2)beta(2)) assembled in complex transgenic-knockout mice. Blood 97(4):1099–1105
Wilber A, Nienhuis AW, Persons DA (2011) Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities. Blood 117:3945–3953
Hardison RC (2012) Evolution of hemoglobin and its genes. Cold Spring Harb Perspect Med 2(12):a011627
Militello V, Vitrano E, Cupane A (1991) The effect of organic cosolvents on the oxygen affinity of fetal hemoglobin. Relevance of protein-solvent interactions to the functional properties. Biophys Chem 39(2):161–169
Dumoulin A, Manning LR, Jenkins WT et al (1997) Exchange of subunit interfaces between recombinant adult and fetal hemoglobins. Evidence for a functional inter-relationship among regions of the tetramer. J Biol Chem 272(50):31326–31332
Chakane S, Matos T, Kettisen K et al (2017) Fetal hemoglobin is much less prone to DNA cleavage compared to the adult protein. Redox Biol 12:114–120
Ratanasopa K, Strader MB, Alayash AI et al (2015) Dissection of the radical reactions linked to fetal hemoglobin reveals enhanced pseudoperoxidase activity. Front Physiol 6:39
Lettre G, Bauer DE (2016) Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies. Lancet 387(10037):2554–2564
Saki N, Abroun S, Soleimani M et al (2016) MicroRNA expression in β-thalassemia and sickle cell disease: a role in the induction of fetal hemoglobin. Cell J 17(4):583–592
Sripichai O, Fucharoen S (2016) Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches. Expert Rev Hematol 9(12):1129–1137
Habara AH, Shaikho EM, Steinberg MH (2017) Fetal hemoglobin in sickle cell anemia: the Arab-Indian haplotype and new therapeutic agents. Am J Hematol 92(11):1233–1242. https://doi.org/10.1002/ajh.24872
Tobian AA, Heddle NM, Wiegmann TL et al (2016) Red blood cell transfusion: 2016 clinical practice guidelines from AABB. Transfusion 56(10):2627–2630
Forbes JM, Anderson MD, Anderson GF et al (1991) Blood transfusion costs: a multicenter study. Transfusion 31(4):318–323
Moradi S, Jahanian-Najafabadi A, Roudkenar MH (2016) Artificial blood substitutes: first steps on the long route to clinical utility. Clin Med Insights Blood Disord 9:33–41
Alayash AI (2014) Blood substitutes: why haven’t we been more successful? Trends Biotechnol 32(4):177–185
Graves PE, Henderson DP, Horstman MJ et al (2008) Enhancing stability and expression of recombinant human hemoglobin in E. coli: progress in the development of a recombinant HBOC source. Biochim Biophys Acta 1784(10):1471–1479
Martínez JL, Liu L, Petranovic D et al (2012) Pharmaceutical protein production by yeast: towards production of human blood proteins by microbial fermentation. Curr Opin Biotechnol 23(6):965–971
Jullesson D, David F, Pfleger B et al (2015) Impact of synthetic biology and metabolic engineering on industrial production of fine chemicals. Biotechnol Adv 33(7):1395–1402
Gutierrez JM, Lewis NE (2015) Optimizing eukaryotic cell hosts for protein production through systems biotechnology and genome-scale modeling. Biotechnol J 10(7):939–949
Nagai K, Perutz MF, Poyart C (1985) Oxygen binding properties of human mutant hemoglobins synthesized in Escherichia coli. Proc Natl Acad Sci U S A 82(21):7252–7255
Wagenbach M, O’Rourke K, Vitez L et al (1991) Synthesis of wild type and mutant human hemoglobins in Saccharomyces cerevisiae. Biotechnology (N Y) 9(1):57–61
Behringer RR, Ryan TM, Reilly MP et al (1989) Synthesis of functional human hemoglobin in transgenic mice. Science 245(4921):971–973
Swanson ME, Martin MJ, O’Donnell JK et al (1992) Production of functional human hemoglobin in transgenic swine. Biotechnology (N Y) 10(5):557–559
Dieryck W, Pagnier J, Poyart C et al (1997) Human haemoglobin from transgenic tobacco. Nature 386(6620):29–30
Komar AA, Kommer A, Krasheninnikov IA et al (1993) Cotranslational heme binding to nascent globin chains. FEBS Lett 326(1–3):261–263
Yip YK, Waks M, Beychok S (1977) Reconstitution of native human hemoglobin from separated globin chains and alloplex intermediates. Proc Natl Acad Sci U S A 74(1):64–68
Hoffman SJ, Looker DL, Roehrich JM et al (1990) Expression of fully functional tetrameric human hemoglobin in Escherichia coli. Proc Natl Acad Sci U S A 87(21):8521–8525
Komar AA, Kommer A, Krasheninnikov IA et al (1997) Cotranslational folding of globin. J Biol Chem 272(16):10646–10651
Hernan RA, Hui HL, Andracki ME et al (1992) Human hemoglobin expression in Escherichia coli: importance of optimal codon usage. Biochemistry 31(36):8619–8628
Kavanaugh JS, Rogers PH, Arnone A (1992) High-resolution X-ray study of deoxy recombinant human hemoglobins synthesized from beta-globins having mutated amino termini. Biochemistry 31(36):8640–8647
Shen TJ, Ho NT, Simplaceanu V et al (1993) Production of unmodified human adult hemoglobin in Escherichia coli. Proc Natl Acad Sci U S A 90(17):8108–8112
Walsh G (2002) Proteins: biochemistry and biotechnology. Wiley, Chichester
Looker D, Abbott-Brown D, Cozart P et al (1992) A human recombinant haemoglobin designed for use as a blood substitute. Nature 356(6366):258–260
Weickert MJ, Pagratis M, Glascock CB et al (1999) A mutation that improves soluble recombinant hemoglobin accumulation in Escherichia coli in heme excess. Appl Environ Microbiol 65(2):640–647
Fronticelli C, Arosio D, Bobofchak KM et al (2001) Molecular engineering of a polymer of tetrameric hemoglobins. Proteins 44(3):212–222
Feng L, Gell DA, Zhou S et al (2004) Molecular mechanism of AHSP-mediated stabilization of alpha-hemoglobin. Cell 119(5):629–640
Gell D, Kong Y, Eaton SA et al (2002) Biophysical characterization of the alpha-globin binding protein alpha-hemoglobin stabilizing protein. J Biol Chem 277(43):40602–40609
Domingues-Hamdi E, Vasseur C, Fournier JB et al (2014) Role of α-globin H helix in the building of tetrameric human hemoglobin: interaction with α-hemoglobin stabilizing protein (AHSP) and heme molecule. PLoS One 9(11):e111395
Vasseur-Godbillon C, Hamdane D, Marden MC et al (2006) High-yield expression in Escherichia coli of soluble human alpha-hemoglobin complexed with its molecular chaperone. Protein Eng Des Sel 19(3):91–97
Ratanasopa K, Cedervall T, Bülow L (2016) Possibilities of using fetal hemoglobin as a platform for producing hemoglobin-based oxygen carriers (HBOCs). Adv Exp Med Biol 876:445–453
Adachi K, Konitzer P, Lai CH et al (1992) Oxygen binding and other physical properties of human hemoglobin made in yeast. Protein Eng 5(8):807–810
Coghlan D, Jones G, Denton KA et al (1992) Structural and functional characterisation of recombinant human haemoglobin A expressed in Saccharomyces cerevisiae. Eur J Biochem 207(3):931–936
Martin de Llano JJ, Schneewind O, Stetler G et al (1993) Recombinant human sickle hemoglobin expressed in yeast. Proc Natl Acad Sci U S A 90(3):918–922
Ogden JE, Harris R, Wilson MT (1994) Production of recombinant human hemoglobin A in Saccharomyces cerevisiae. Methods Enzymol 231:374–390
Liu L, Martínez JL, Liu Z et al (2014) Balanced globin protein expression and heme biosynthesis improve production of human hemoglobin in Saccharomyces cerevisiae. Metab Eng 21:9–16
Martínez JL, Liu L, Petranovic D et al (2015) Engineering the oxygen sensing regulation results in an enhanced recombinant human hemoglobin production by Saccharomyces cerevisiae. Biotechnol Bioeng 112(1):181–188
Zhang L, Hach A (1999) Molecular mechanism of heme signaling in yeast: the transcriptional activator Hap1 serves as the key mediator. Cell Mol Life Sci 56(5–6):415–426
Hoffman M, Góra M, Rytka J (2003) Identification of rate-limiting steps in yeast heme biosynthesis. Biochem Biophys Res Commun 310(4):1247–1253
Dailey HA (2002) Terminal steps of haem biosynthesis. Biochem Soc Trans 30(4):590–595
Pfeifer K, Kim KS, Kogan S et al (1989) Functional dissection and sequence of yeast HAP1 activator. Cell 56(2):291–301
Kwast KE, Burke PV, Poyton RO (1998) Oxygen sensing and the transcriptional regulation of oxygen-responsive genes in yeast. J Exp Biol 201(Pt 8):1177–1195
Ter Linde JJ, Steensma HY (2002) A microarray-assisted screen for potential Hap1 and Rox1 target genes in Saccharomyces cerevisiae. Yeast 19(10):825–840
Keng T (1992) HAP1 and ROX1 form a regulatory pathway in the repression of HEM13 transcription in Saccharomyces cerevisiae. Mol Cell Biol 12(6):2616–2623
Guarente L, Mason T (1983) Heme regulates transcription of the CYC1 gene of S. cerevisiae via an upstream activation site. Cell 32(4):1279–1286
Zhang L, Guarente L (1994) Evidence that TUP1/SSN6 has a positive effect on the activity of the yeast activator HAP1. Genetics 136(3):813–817
Yu J, Jiang J, Fang Z et al (2010) Enhanced expression of heterologous inulinase in Kluyveromyces lactis by disruption of hap1 gene. Biotechnol Lett 32(4):507–512
Sassa S (1996) Sequential induction of heme pathway enzymes during erythroid differentiation of mouse Friend leukemia virus-infected cells. J Exp Med 143(2):305–315
Michener JK, Nielsen J, Smolke CD (2012) Identification and treatment of heme depletion attributed to overexpression of a lineage of evolved P450 monooxygenases. Proc Natl Acad Sci U S A 109(47):19504–19509
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ishchuk, O.P., Martínez, J.L., Petranovic, D. (2019). Improving the Production of Cofactor-Containing Proteins: Production of Human Hemoglobin in Yeast. In: Gasser, B., Mattanovich, D. (eds) Recombinant Protein Production in Yeast. Methods in Molecular Biology, vol 1923. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9024-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9024-5_11
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9023-8
Online ISBN: 978-1-4939-9024-5
eBook Packages: Springer Protocols